Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 56 Head & Neck 8 Thoracic 4 Breast 4 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 153 Carboplatin 123 Bevacizumab 88 Cisplatin 66 pembrolizumab 58 Taxes 51 Gemcitabine 51 liposomal doxorubicin 39 Topotecan 37 olaparib 32 Immunoglobulin G 27 Disulfides 26 Cyclophosphamide 24 Brachytherapy 22 Docetaxel 21 human papillomavirus vaccine, L1 type 16, 18 20 niraparib 19 Platinum 19 Nivolumab 18 Magnetic Resonance Spectroscopy 18 1,2-diaminocyclohexaneplatinum II citrate 18 rucaparib 17 durvalumab 17 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 16 Doxorubicin 16 Radiotherapy, Intensity-Modulated 14 Radiation 13 Albumin-Bound Paclitaxel 13 fludarabine phosphate 12 fludarabine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Panitumumab × Gynecologic × Clear all

NCT01296035 2015-08-25

PanGem

Women and Infants Hospital of Rhode Island

Phase 2 Terminated

8 enrolled 6 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡